GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 188 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,860,000 | +508.5% | 42,003 | +209.8% | 0.00% | – |
Q1 2022 | $470,000 | -54.7% | 13,559 | -61.7% | 0.00% | – |
Q4 2021 | $1,037,000 | +97.1% | 35,405 | +135.6% | 0.00% | – |
Q2 2021 | $526,000 | -60.2% | 15,028 | -53.6% | 0.00% | – |
Q1 2021 | $1,322,000 | -12.3% | 32,410 | -6.9% | 0.00% | -100.0% |
Q4 2020 | $1,507,000 | +12.2% | 34,809 | +42.8% | 0.00% | 0.0% |
Q3 2020 | $1,343,000 | -67.0% | 24,368 | -62.2% | 0.00% | -50.0% |
Q2 2020 | $4,071,000 | +225.9% | 64,483 | +164.0% | 0.00% | +100.0% |
Q1 2020 | $1,249,000 | -48.4% | 24,425 | -19.9% | 0.00% | 0.0% |
Q4 2019 | $2,422,000 | +116.8% | 30,477 | +32.4% | 0.00% | 0.0% |
Q3 2019 | $1,117,000 | +3.1% | 23,021 | +11.9% | 0.00% | – |
Q2 2019 | $1,083,000 | -1.1% | 20,581 | -0.6% | 0.00% | -100.0% |
Q1 2019 | $1,095,000 | +133.0% | 20,700 | +80.2% | 0.00% | – |
Q4 2018 | $470,000 | -78.9% | 11,486 | -76.7% | 0.00% | -100.0% |
Q2 2018 | $2,228,000 | -38.5% | 49,303 | -34.3% | 0.00% | -50.0% |
Q1 2018 | $3,622,000 | +192.1% | 75,002 | +138.1% | 0.00% | +100.0% |
Q4 2017 | $1,240,000 | -2.8% | 31,499 | -23.4% | 0.00% | 0.0% |
Q3 2017 | $1,276,000 | +14.5% | 41,126 | +1.0% | 0.00% | 0.0% |
Q2 2017 | $1,114,000 | -26.2% | 40,724 | -0.6% | 0.00% | 0.0% |
Q1 2017 | $1,510,000 | – | 40,972 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |